Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience.
Van Dyke DL, Werner L, Rassenti LZ, Neuberg D, Ghia E, Heerema NA, Dal Cin P, Dell Aquila M, Sreekantaiah C, Greaves AW, Kipps TJ, Kay NE. Van Dyke DL, et al. Br J Haematol. 2016 Apr;173(1):105-13. doi: 10.1111/bjh.13933. Epub 2016 Feb 5. Br J Haematol. 2016. PMID: 26848054 Free PMC article. Clinical Trial.
Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) Study.
Heerema NA, Byrd JC, Dal Cin PS, Dell' Aquila ML, Koduru PR, Aviram A, Smoley SA, Rassenti LZ, Greaves AW, Brown JR, Rai KR, Kipps TJ, Kay NE, Van Dyke DL; Chronic Lymphocytic Leukemia Research Consortium. Heerema NA, et al. Among authors: van dyke dl. Cancer Genet Cytogenet. 2010 Dec;203(2):134-40. doi: 10.1016/j.cancergencyto.2010.07.128. Cancer Genet Cytogenet. 2010. PMID: 21156225 Free PMC article.
Standardization of fluorescence in situ hybridization studies on chronic lymphocytic leukemia (CLL) blood and marrow cells by the CLL Research Consortium.
Smoley SA, Van Dyke DL, Kay NE, Heerema NA, Dell' Aquila ML, Dal Cin P, Koduru P, Aviram A, Rassenti L, Byrd JC, Rai KR, Brown JR, Greaves AW, Eckel-Passow J, Neuberg D, Kipps TJ, Dewald GW. Smoley SA, et al. Among authors: van dyke dl. Cancer Genet Cytogenet. 2010 Dec;203(2):141-8. doi: 10.1016/j.cancergencyto.2010.08.009. Cancer Genet Cytogenet. 2010. PMID: 21156226 Free PMC article.
Metaphase cells with normal G-bands have cryptic interstitial deletions in 13q14 detectable by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia.
Stockero KJ, Fink SR, Smoley SA, Paternoster SF, Shanafelt TD, Call TG, Zent CS, Van Dyke DL, Kay NE, Dewald GW. Stockero KJ, et al. Among authors: van dyke dl. Cancer Genet Cytogenet. 2006 Apr 15;166(2):152-6. doi: 10.1016/j.cancergencyto.2005.10.011. Cancer Genet Cytogenet. 2006. PMID: 16631472
Progressive but previously untreated CLL patients with greater array CGH complexity exhibit a less durable response to chemoimmunotherapy.
Kay NE, Eckel-Passow JE, Braggio E, Vanwier S, Shanafelt TD, Van Dyke DL, Jelinek DF, Tschumper RC, Kipps T, Byrd JC, Fonseca R. Kay NE, et al. Among authors: van dyke dl. Cancer Genet Cytogenet. 2010 Dec;203(2):161-8. doi: 10.1016/j.cancergencyto.2010.09.003. Cancer Genet Cytogenet. 2010. PMID: 21156228 Free PMC article.
CLL update 2022: A continuing evolution in care.
Kay NE, Hampel PJ, Van Dyke DL, Parikh SA. Kay NE, et al. Among authors: van dyke dl. Blood Rev. 2022 Jul;54:100930. doi: 10.1016/j.blre.2022.100930. Epub 2022 Jan 26. Blood Rev. 2022. PMID: 35151528 Review.
227 results